Thrombotic thrombocytopenic purpura mediated by an ADAMTS13-inhibitor related to a treatment with pegylated-interferon alpha-2a and ribavirine in a patient with chronic hepatitis C

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	La Presse médicale (1983) 2010-11, Vol.39 (11), p.1207-1210
Hauptverfasser:	Lambot, Frédéric, Hanson, Bernard, Sztern, Bernard
Format:	Artikel
Sprache:	fre
Schlagworte:	ADAM Proteins - immunology ADAMTS13 Protein Adult Antiviral Agents - adverse effects Autoantibodies - immunology Female Hepatitis C, Chronic - drug therapy Humans Interferon-alpha - adverse effects Polyethylene Glycols - adverse effects Purpura, Thrombotic Thrombocytopenic - chemically induced Purpura, Thrombotic Thrombocytopenic - immunology Recombinant Proteins Ribavirin - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!